XML 60 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Net revenues $ 12,160,000 $ 9,003,000
Net revenues – related party 887,000 669,000
Total net revenues 13,047,000 9,672,000
Cost of revenues 7,351,000 7,479,000
Gross profit 5,696,000 2,193,000
Expenses:    
Sales and marketing 1,656,000 1,359,000
Research and development 2,396,000 3,012,000
General and administrative 6,377,000 8,286,000
Impairment charges 33,081,000
Total operating expenses 10,429,000 45,738,000
Loss from operations (4,733,000) (43,545,000)
Fair value change of derivative instruments 1,000 596,000
Interest expense (4,479,000) (2,697,000)
Loss on extinguishment of debt (840,000)
Loss on equity method investments (15,000)
Other expenses (33,000) (24,000)
Total other expense (5,366,000) (2,125,000)
Loss before benefit for income taxes (10,099,000) (45,670,000)
Benefit for income taxes 0 4,730,000
Net loss (10,099,000) (40,940,000)
Loss attributable to non-controlling interests (602,000) (1,224,000)
Net loss attributable to common stockholders (9,497,000) (39,716,000)
Net loss (10,099,000) (40,940,000)
Other comprehensive loss:    
Foreign currency translation adjustments 15,000 30,000
Comprehensive loss (10,084,000) (40,910,000)
Comprehensive loss attributable to non-controlling interests (602,000) (1,224,000)
Comprehensive loss attributable to common stockholders $ (9,482,000) $ (39,686,000)
Per share data:    
Basic and diluted net loss per common share (in dollars per share) $ (3.36) $ (21.57)
Weighted average common shares outstanding Basic and diluted (in shares) 2,828,606 1,841,281